Pfizer Announces Positive Top-Line Data of Phase 3 Global Maternal Immunization Trial for its Bivalent Respiratory Syncytial Virus Vaccine Candidate Pharmaceutical Investing
Ortho Dermatologics Announces U.S. Launch of the Podiatry Board Review Challenge Pharmaceutical Investing
Bristol Myers Squibb Announces Positive Topline Results of Phase 3 COMMANDS Trial Pharmaceutical Investing
Aurinia Pharmaceuticals to Release Third Quarter 2022 Financial and Operational Results on November 3, 2022 Pharmaceutical Investing
Abbott's FreeStyle Libre® is Named Best Medical Technology in Last 50 Years by the Galien Foundation Pharmaceutical Investing
AbbVie Announces Submissions of Regulatory Applications for Epcoritamab for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Large B-Cell Lymphoma Pharmaceutical Investing
Obsidian Therapeutics Announces Extension of Multi-Year Collaboration Agreement with Bristol Myers Squibb Pharmaceutical Investing
